Eribulin
Drug timelines are a Plus or Pro feature.
49 regulatory and trial events tracked for Eribulin, covering 2012-01-27 to 2026-04-23. Get the full timeline:
Most recent: Clinical Trial Update: Phase III Trial of Camrelizumab+Apatinib+Eribulin vs. Physician's Choice Chemotherapy in Advanced Triple-Negative Breast Cancer [Phase 3]